Tokyo Guideline 2013 (TG13) is an international guideline for the diagnosis, classification and treatment of acute cholangitis. Progress and controversy for the two years after TG13 was summarized. Endoscopic ultrasound (EUS) and magnetic resonance cholan
Tokyoguideline2013((TG13)) is an international guideline for the diagnosis, classification and treatment ofAcutecholangitis. Progress and controversy for the two years after TG13 was summarized.endoscopicultrasound (EUS) and magnetic resonance cholangiopancreatography (MRCP) are both effective imaging tests forcommonbileduct(CBD) stones. More factors e.g. obesity may be involved in severity assessment. Initiation of broad-spectrum antibiotics addressing the typical Gram-negative enteric bacteria spectrum and early biliary drainage are the mainstay therapeutic options. Earlylaparoscopicexplorationis also an option for stone-related nonsevere acute cholangitis besides endoscopicretrogradecholangial or p(ERC)utaneoustranshepaticcholangial drainage. Surgical biliary drainage should be avoided in severe cholangitis.
阅读全文请见:Controversy and progress for treatment of acute cholangitis after Tokyo Guidelines (TG13)
copyright© 版权所有,未经许可不得复制、转载或镜像
京ICP证120392号 京公网安备110105007198 京ICP备10215607号-1 (京)网药械信息备字(2022)第00160号